C3435T polymorphism of the MDR1 gene is not associated with P-glycoprotein function of leukemic blasts and clinical outcome in patients with acute myeloid leukemia.
暂无分享，去创建一个
Je-Hwan Lee | H. Chi | Chan-Jeoung Park | Jung-Hee Lee | K. Lee | Eun-Hye Hur | M. Seol | Young-Shin Lee | Y. Jang | S. Shim | Seong-jun Choi | M. Lee | Seong-Gil Ryu | M. Kang | Y. Kang | Hee-Jung Lee | I. Kang
[1] P. Sonneveld,et al. ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients , 2006, Clinical pharmacology and therapeutics.
[2] T. Robak,et al. No Influence of 3435C>T ABCB1 (MDR1) Gene Polymorphism on Risk of Adult Acute Myeloid Leukemia and P-glycoprotein Expression in Blast Cells , 2006, Therapeutic drug monitoring.
[3] Y. Do,et al. Multidrug resistance‐1 gene polymorphisms associated with treatment outcomes in de novo acute myeloid leukemia , 2006 .
[4] J. Park,et al. Multidrug resistance-1 gene polymorphisms associated with treatment outcomes in de novo acute myeloid leukemia. , 2005, International journal of cancer.
[5] R. Kim,et al. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. , 2002, Cancer research.
[6] U. Brinkmann,et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[7] I. Pastan,et al. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. , 1999, Annual review of pharmacology and toxicology.